Six Months Of Herceptin Could Be As Effective As 12 Months For Some Women With HER2 Positive Breast Cancer | Latest News RSS feed

Six Months Of Herceptin Could Be As Effective As 12 Months For Some Women With HER2 Positive Breast Cancer - Latest News


Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer

For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new resear... read more

You've been diagnosed with breast cancer. Now what?

Women with HER2-positive breast cancer will receive antiHER2 therapy, initially with chemotherapy and then by itself to complete 12 months of antiHER2 therapy. These treatments can ... effective as ma... read more

Breast Cancer Patients May Shorten Herceptin Regimen: Study

"HER2-positive breast cancer ... of the women took Herceptin for six months, while the other half remained on the standard 12-month regimen. Outcomes were tracked for four years. Earl's group reported ... read more

Looking for another news?


Study: Shorter drug treatment OK for many breast cancer patients

Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage i... read more


Reducing Use of Roche Drug for Breast Cancer Didn't Hurt Efficacy, Study Says

The study, funded by the U.K. National Institute for Health Research, was conducted on more than 4,000 women in the early stages of an aggressive type of breast cancer known as HER2-positive. Hercepti... read more

Shorter trastuzumab treatment for HER2+ breast cancer can be as effective, with fewer cardiac side-effects

Explore further: Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer read more

How drug treatment in Hong Kong changed Aussie cancer sufferer’s life

Now that my tumour markers are good ... next six to 12 months … We can only hope.” Palbociclib and ribociclib are in a class of drugs that are used to delay progression of hormone receptorpositive, HE... read more

Hempfield teacher keeps a positive outlook as she battles breast cancer, urges women to get mammograms

Six months earlier ... was diagnosed with 90 percent estrogen-positive, 5 percent progesteron-positive, HER2-positive, invasive ductal carcinoma breast cancer. In layman’s terms, the lump ... read more

Mining For ASCO 2018's Gold, Part 1: Early Breast Cancer Has Some Sheen

Puma's drug seems to work a lot better if you can ... HER2-positive breast cancer. However, it remains unclear what the duration of adjuvant therapy might be. Neratinib was previously shown to improve ... read more

'I travel 11,000km for breast cancer treatment'

Now that my tumour markers are good ... next six to 12 months... We can only hope.” Palbociclib and ribociclib are in a class of drugs that are used to delay progression of hormone receptor-positive, ... read more

Shorter trastuzumab treatment for HER2+ breast cancer can be as effective, with fewer cardiac side-effects

A phase III randomized clinical trial of 4,088 women with HER2-positive, early-stage breast cancer found that taking trastuzumab (Herceptin) for 6 months was non-inferior to the current standard of 12 ... read more

Breast Cancer: Seeking The Next Blockbuster

Herceptin's annual sales of $5.6 billion in 2011 far exceed Tykerb's sales of $231 million. Tykerb is an oral drug for patients with advanced, metastatic, HER2-positive breast cancer ... who had a med... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us